Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Stocks - Europe Higher on Relief at Fund Breakthrough; UBS Surges

Published 07/21/2020, 03:34 AM
Updated 07/21/2020, 03:35 AM
© Reuters.
EUR/USD
-
UK100
-
XAU/USD
-
FCHI
-
DE40
-
KO
-
NOVN
-
RCOP
-
GC
-
LCO
-
CL
-
UAL
-
ENT
-
UBSG
-

By Peter Nurse 

Investing.com - European stock markets pushed higher Tuesday, boosted by the European Union leaders agreeing on a massive stimulus plan to help rebuild the economies damaged by the coronavirus pandemic.

At 3:35 AM ET (0735 GMT), the DAX in Germany traded 1.6% higher, the CAC 40 in France rose 1.2% and the U.K.'s FTSE index was up 0.6%. 

After almost five days of haggling, the leaders agreed on a compromise that cut the share of grants within the 750 billion-euro envelope to 390 billion euros, down from 500 billion euros originally proposed, and the rest in repayable loans.

That comes on top of the seven-year one trillion euro EU budget that had been a source of contention even before the pandemic.

"This is an important signal beyond Europe's borders that the EU, even with all the (EU member states') varying backgrounds, is able to take action," German Chancellor Angela Merkel told reporters during a joint news conference with French President Emmanuel Macron. 

In corporate news, UBS (SIX:UBSG) stock rose 3.1% after the Swiss banking giant announced a net profit of $1.23 billion for the second quarter, down 11% from the same period last year, but ahead of analysts’ expectations.

Remy Cointreau (PA:RCOP) climbed 4.8% after the French spirits maker said sales for the first quarter of its fiscal year came in above expectations and raised its half-year guidance.

On the flip side, GVC Holdings (LON:GVC) dropped 7.9% after the news that the British tax authorities had expanded an investigation into the gambling company's former online business in Turkey to include unidentified entities within the London-listed group.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Novartis (SIX:NOVN) fell 0.8% after its net profit and sales declined in the second quarter with medicine stockpiling triggered by the coronavirus pandemic in the previous quarter largely reversing.

Attention will turn later in the session onto the U.S. corporate earnings season, with several big household names due to report Tuesday including Coca-Cola Company (NYSE:KO) and United Airlines Holdings (NASDAQ:UAL). 

U.S. policymakers are also set to discuss their next steps in responding to the coronavirus crisis later Tuesday, with investors expecting another economic package in the near future given some earlier measures are set to expire at the end of the July.

Oil prices edged higher Tuesday, with the American Petroleum Institute’s weekly report on U.S. oil stockpiles due later in the session.

At 3:35 AM ET, U.S. crude futures traded 0.6% higher at $41.16 a barrel, while the international benchmark Brent contract rose 0.7% to $43.60.

Elsewhere, gold futures rose 0.4% to $1,823.90/oz, while EUR/USD traded at 1.1446, up 0.1%.

Latest comments

huge piles of money on the sidelines started to lose patience and slowly but steadily poured into equities. short sellers started to cover for sure. sellers have become less active and started taking a wait-n-see attitude.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.